A Closer Look at the Clinical, Economic
and Developmental Impact of Atopic Dermatitis: Strategies to Improve
Patient Adherence, Quality of Life, Costs and Work Productivity
A continuing medical education activity sponsored by NAMCP and AAMCN.
Confronting the Clinical and Economic
Burden of Atopic Dermatitis:
Managed Care Considerations in an Evolving Treatment Paradigm
This is Part 3 of the series focusing on the strategies to improve
quality of life, costs, and work productivity
This activity is an archive from the webinar held May 22, 2020
This activity is valid from June 1, 2020 to
June 1, 2022
Instructions for CME/NCPD: Complete the pre-test, listen to the
audio and view the slides, complete the post test, complete the
evaluation form and hit submit. You will be asked to enter your name
and email address on the pre-test, evaluation, and post-test. If you
close your internet browser without completing the post test, you
will have ONE more opportunity to complete. A score of 70% must be
achieved on the post-test to receive continuing education credits.
If you do not pass the post-test after two attempts, you will not be
eligible to try again. Once you complete the evaluation form and
score 70% or higher on your post-test, you will automatically be
given your certificate.
To print or save your certificate, you will need to click on the
“download” button and either print or save.
Audience: This activity is intended for
healthcare professionals practicing in managed care environments.
This presentation is supported by
an educational grant from
Atopic dermatitis is a common chronic inflammatory skin disease
characterized by persistent itching that can severely affect quality
of life. This condition evolves from a combination of skin barrier
defects and immune-mediated responses involving activated T-helper
cells and related cytokines. Fortunately for patients with this
disease, several new treatments have recently become available, and
more are on the horizon, including JAK inhibitors, that have shown
improved efficacy and safety, offering patients the potential for
improved outcomes and quality of life.
Upon completion of this
activity, participants will be able to:
Explore challenges to patient
adherence and quality of life in atopic dermatitis (AD)
Examine the economic burden of AD on
patient’s productivity and quality of life
Assess how different biomarkers,
comorbidities and adherence barriers play a role in long-term
treatment decision making for patients with AD
Review recent clinical data around
the safety of emerging JAK inhibitors currently undergoing
clinical studies and their effect on patient quality of life
||Eric L. Simpson, MD, MCR
Director, Clinical Research
Department of Dermatology
Oregon Health & Science University
serves as a consultant and has received grant/research
support from Pfizer, Lilly, Incyte, Abbvie, Regeneron/Sanofi,
Genentech, GSK, Leo, Celgene, Dermira, Tioga, and
Kiniksa. His presentation has been peer reviewed for any
MD has no relevant financial relationships to disclose.
Jeremy Williams has no relevant financial relationships
Will Williams has no relevant financial relationships to
Jacqueline Cole, RN, MS, CMCN has no relevant financial
relationships to disclose.
NAMCP and/or the presenter
has copyright or has received permissions for use of
materials provided in this activity.
Accreditation & Designation
This activity has been planned and implemented in accordance with
the accreditation requirements and policies of the Accreditation
Council for Continuing Medical Education (ACCME) through the joint
providership of the National Association of Managed Care Physicians
(NAMCP) and American Association of Managed Care Nurses (AAMCN). The
National Association of Managed Care Physicians is accredited by the
ACCME to provide continuing medical education for physicians.
NAMCP designates this enduring material for a maximum of 1 AMA
PRA Category 1 credit(s)TM. Each
physician should claim credit commensurate with the extent of their
participation in the activity.
The American Association of Managed Care Nurses is accredited as a
provider of nursing continuing professional development by the
American Nurses Credentialing Center's Commission on Accreditation.
Nurses who complete this activity and achieve a passing score will
receive 1 hour in nursing continuing professional development.
This activity has been approved by the American Board of Managed
Care Nursing for 1.0 contact hours toward CMCN recertification
This presentation is supported by an
educational grant from
NAMCP and/or this website does not
provide medical advice, diagnosis or treatment. NAMCP does not
endorse or imply endorsement of the content on any linked website.
This website is to be used as an informational resource. With any
health related concern, consult with your physician or healthcare
Click Here To Continue